2006Journal of Jinhua College of Profession and TechnologyRequires access

A Curative Effect Analysis of Simvastatin-Treating Fatty liver

Guoliang Gong

Open publisher page 0 citations

Abstract

Objective: To probe into the clinical curative effect of Simvastatin Tablets in treating fatty liver.Method: 120 cases with fatty liver are divided at random into two groups.60 cases of Simvastatin group take 20 ml Simvastatin rally every day;60 cases of Xuezhikang group take 600 ml Xuezhikang daily,two times a day.Eight weeks as a course of medical treatment,the treatment demands three courses.The curative effect,the change of blood fat and B ultrasonic waves before and after the treatment of the two groups are observed.At the same time 70 healthy people are chosen as a contrasting group.Result: There exist similarities(P0.05) between Simvastatin group(93.1) and Xuezhikang group(90.3);Simvastatin group and Xuezhikang group demonstrate a significant improvement in TC,TG and HDL-C after the treatment.Simvastatin group is better than Xuezhikang group(P 0.05 or P 0.01).Liver functions of the two groups improved greatly after the treatment(P 0.01).But there exist no significance between two groups after the treatment.(P0.05) and there are no serious side effects.Result: Simvastatin is one of the effective ways to treat high blood lipid and fatty liver,and it is also safe with little side effect and deserves to be used in clinical treatment.

About this research paper

What this paper is about

Objective: To probe into the clinical curative effect of Simvastatin Tablets in treating fatty liver.Method: 120 cases with fatty liver are divided at random into two groups.60 cases of Simvastatin group take 20 ml Simvastatin rally every day;60 cases of Xuezhikang group take 600 ml Xuezhikang daily,two times a day.Eight weeks as a course of medical treatment,the treatment demands three courses.The curative effect,the change of blood fat and B ultrasonic waves before and after the treatment of the two groups are observed.At the same time 70 healthy people are chosen as a contrasting group.Result: There exist similarities(P0.05) between Simvastatin group(93.1) and Xuezhikang group(90.3);Simvastatin group and Xuezhikang group demonstrate a significant improvement in TC,TG and HDL-C after the treatment.Simvastatin group is better than Xuezhikang group(P 0.05 or P 0.01).Liver functions of the two groups improved greatly after the treatment(P 0.01).But there exist no significance between two groups after the treatment.(P0.05) and there are no serious side effects.Result: Simvastatin is one of the effective ways to treat high blood lipid and fatty liver,and it is also safe with little side effect and deserves to be used in clinical treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To probe into the clinical curative effect of Simvastatin Tablets in treating fatty liver.Method: 120 cases with fatty liver are divided at random into two groups.60 cases of Simvastatin group take 20 ml Simvastatin rally every day;60 cases of Xuezhikang group take 600 ml Xuezhikang daily,two times a day.Eight weeks as a course of medical treatment,the treatment demands three courses.The curative effect,the change of blood fat and B ultrasonic waves before and after the treatment of the two groups are observed.At the same time 70 healthy people are chosen as a contrasting group.Result: There exist similarities(P0.05) between Simvastatin group(93.1) and Xuezhikang group(90.3);Simvastatin group and Xuezhikang group demonstrate a significant improvement in TC,TG and HDL-C after the treatment.Simvastatin group is better than Xuezhikang group(P 0.05 or P 0.01).Liver functions of the two groups improved greatly after the treatment(P 0.01).But there exist no significance between two groups after the treatment.(P0.05) and there are no serious side effects.Result: Simvastatin is one of the effective ways to treat high blood lipid and fatty liver,and it is also safe with little side effect and deserves to be used in clinical treatment.

Key concepts: Simvastatin, Medicine, Fatty liver, Gastroenterology, Internal medicine, Blood lipids, Cholesterol, Disease

Related papers

Back to paper searchBrowse research topicsOriginal source
A Curative Effect Analysis of Simvastatin-Treating Fatty liver — Research Paper | ScholarLens